Applied DNA Sciences, Inc. (NASDAQ:APDN) Sees Significant Decrease in Short Interest

Applied DNA Sciences, Inc. (NASDAQ:APDN) was the target of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 477,000 shares, a decline of 21.9% from the October 31st total of 611,100 shares. Based on an average trading volume of 4,310,000 shares, the short-interest ratio is currently 0.1 days.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Applied DNA Sciences to a “sell” rating in a research report on Tuesday, September 17th.

Hedge Funds Weigh In On Applied DNA Sciences

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Jane Street Group LLC acquired a new stake in Applied DNA Sciences, Inc. (NASDAQ:APDN) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 73,396 shares of the technology company’s stock, valued at approximately $48,000. Jane Street Group LLC owned approximately 0.24% of Applied DNA Sciences as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Stock Performance

APDN stock opened at $0.15 on Friday. The business’s fifty day moving average price is $0.33 and its 200 day moving average price is $0.76. Applied DNA Sciences has a 12-month low of $0.15 and a 12-month high of $22.80. The company has a market capitalization of $7.74 million, a PE ratio of -0.01 and a beta of 0.46.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.